Evaxion A/S (EVAX) — research page

US · us-cm-kg/NASDAQ/EVAX · as of 2026-11-08

Identity and listing

The issuer is Evaxion A/S, listed on NASDAQ under the ticker EVAX, with ISIN US29970R3030. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-G7 was found. The security type is Non-operating entity type (other). The segment is not on the record. The sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is Denmark. The issuer is listed and not halted.

The disclosure read

The record holds 63 filings in the twelve months to 2026-11-08, across 47 filing days. The filings comprise 16 directors' dealings, 2 prospectuses and 45 results. The median gap between filing days is 4.0 days. The latest filing is dated 2026-11-06, two days before the record date, and is of type results. On NASDAQ the median filings count is 52, the median cadence gap is 6.0 days and the median latency is 5.0 days across 4359 issuers. In the sector the median filings count is 65.5, the median cadence gap is 5.5 days and the median latency is 4.0 days across 176 issuers. The issuer's 63 filings are above the exchange median of 52 and below the sector median of 65.5.

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed, not halted.

Orderability

The outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

Five research houses are named on the issuer's investor-relations page: HC Wainwright, Ladenburg Thalmann, Lake Street, Jones Trading and Maxim Group LLC.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

As-of depth

The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1

https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)

10.2

https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)

10.3

https://data.sec.gov/submissions/CIK0001828253.json (identity.jurisdiction)

10.4

https://mcp.us-cm-kg.ai/events/NASDAQ/EVAX (the disclosure lines)

10.5

https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)

10.6

https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)

10.7

https://investors.evaxion.ai/investors/stock-info/ (coverage)

10.8

https://mcp.us-cm-kg.ai/record/NASDAQ/EVAX (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US29970R3030"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:5952826d404bca9b.